426
Views
16
CrossRef citations to date
0
Altmetric
Reviews

How far have we reached in development of effective influenza vaccine?

, , , &
Pages 266-276 | Received 22 Apr 2018, Accepted 11 Jul 2018, Published online: 25 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Hongtao Ren, Yali Wang, Ya Guo, Mincong Wang, Xiulong Ma, Wen Li, Yuyan Guo & Yiming Li. (2022) Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression. Bioengineered 13:4, pages 9780-9791.
Read now
Jieying Luo, Junaid Ahmed Shaikh, Lei Huang, Lei Zhang, Shahid Iqbal, Yu Wang, Bojiang Liu, Quan Zhou, Aisha Ajmal, Maryam Rizvi, Maryam Ajmal & Yingwu Liu. (2022) Human Plasma Metabolomics Identify 9-cis-retinoic Acid and Dehydrophytosphingosine Levels as Novel biomarkers for Early Ventricular Fibrillation after ST-elevated Myocardial Infarction. Bioengineered 13:2, pages 3334-3350.
Read now

Articles from other publishers (9)

Irina V. Kiseleva & Larisa G. Rudenko. (2023) Development of reassortant influenza vaccines: classical reassortment or reverse genetics?. Russian Journal of Infection and Immunity 13:2, pages 209-218.
Crossref
Evgeny Pashkov, Ekaterina Korchevaya, Evgeny Faizuloev, Artem Rtishchev, Bogdan Cherepovich, Elizaveta Bystritskaya, Alexander Sidorov, Alexander Poddubikov, Anatoly Bykov, Yuliya Dronina, Oxana Svitich & Vitaliy Zverev. (2022) Knockdown of FLT4, Nup98, and Nup205 Cellular Genes Effectively Suppresses the Reproduction of Influenza Virus Strain A/WSN/1933 (H1N1) In vitro. Infectious Disorders - Drug Targets 22:5.
Crossref
E. A. Pashkov, M. O. Korotysheva, A. V. Pak, E. B. Faizuloev, A. V. Sidorov, A. V. Poddubikov, E. P. Bystritskaya, Y. E. Dronina, V. K. Solntseva, T. A. Zaiceva, E. P. Pashkov, A. S. Bykov, O. A. Svitich & V. V. Zverev. (2022) Investigation of the anti-influenza activity of siRNA complexes against the cellular genes <i>FLT4, Nup98</i>, and <i>Nup205 in vitro</i>. Fine Chemical Technologies 17:2, pages 140-151.
Crossref
E. A. Pashkov, E. B. Faizuloev, E. R. Korchevaya, A. A. Rtishchev, B. S. Cherepovich, А. V. Sidorov, A. V. Poddubikov, Е. P. Bystritskaya, Yu. E. Dronina, A. S. Bykov, O. А. Svitich & V. V. Zverev. (2022) Knockdown of <i>FLT4</i>, <i>Nup98</i>, and <i>Nup205</i> cellular genes as a suppressor for the viral activity of Influenza A/WSN/33 (H1N1) in A549 cell culture. Fine Chemical Technologies 16:6, pages 476-489.
Crossref
Rossella Cianci, Estelle E. Newton & Danilo Pagliari. (2020) Efforts to Improve the Seasonal Influenza Vaccine. Vaccines 8:4, pages 645.
Crossref
Senlian Hong, Geramie Grande, Chenhua Yu, Digantkumar G. Chapla, Natalie Reigh, Jeong-Yeh Yang, Yi Yang, Ken Izumori, Kelley W. Moremen, Jia Xie & Peng Wu. (2020) hFUT1-Based Live-Cell Assay To Profile α1-2-Fucoside-Enhanced Influenza Virus A Infection. ACS Chemical Biology 15:4, pages 819-823.
Crossref
Angela Paul Peter, Chew Kit Wayne, Pau Loke Show & Tau Chuan Ling. (2020) Potential Pathway that Could Treat Coronaviruses (COVID-19). Current Biochemical Engineering 6:1, pages 3-4.
Crossref
J. Reina & N. Reina. (2019) Universal influenza vaccination: Future prospects. Vacunas (English Edition) 20:2, pages 72-81.
Crossref
J. Reina & N. Reina. (2019) Vacunación antigripal universal: perspectivas de futuro. Vacunas 20:2, pages 72-81.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.